• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X连锁性肌管性肌病犬模型的步态特征

Gait characteristics in a canine model of X-linked myotubular myopathy.

作者信息

Goddard Melissa A, Burlingame Emily, Beggs Alan H, Buj-Bello Anna, Childers Martin K, Marsh Anthony P, Kelly Valerie E

机构信息

Department of Physiology and Pharmacology, School of Medicine, Wake Forest University, Winston-Salem, NC 27109, USA.

Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC 27109, USA.

出版信息

J Neurol Sci. 2014 Nov 15;346(1-2):221-6. doi: 10.1016/j.jns.2014.08.032. Epub 2014 Aug 29.

DOI:10.1016/j.jns.2014.08.032
PMID:25281397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4253544/
Abstract

X-linked myotubular myopathy (XLMTM) is a fatal pediatric disease where affected boys display profound weakness of the skeletal muscles. Possible therapies are under development but robust outcome measures in animal models are required for effective translation to human patients. We established a naturally-occurring canine model, where XLMTM dogs display clinical symptoms similar to those observed in humans. The aim of this study was to determine potential endpoints for the assessment of future treatments in this model. Video-based gait analysis was selected, as it is a well-established method of assessing limb function in neuromuscular disease and measures have been correlated to the patient's quality of life. XLMTM dogs (N = 3) and their true littermate wild type controls (N = 3) were assessed at 4-5 time points, beginning at 10 weeks and continuing through 17 weeks. Motion capture and an instrumented carpet were used separately to evaluate spatiotemporal and kinematic changes over time. XLMTM dogs walk more slowly and with shorter stride lengths than wild type dogs, and these differences became greater over time. However, there was no clear difference in angular measures between affected and unaffected dogs. These data demonstrate that spatiotemporal parameters capture functional changes in gait in an XLMTM canine model and support their utility in future therapeutic trials.

摘要

X连锁性肌管性肌病(XLMTM)是一种致命的儿科疾病,患病男孩表现出严重的骨骼肌无力。目前正在研发可能的治疗方法,但要有效地转化应用于人类患者,需要在动物模型中建立可靠的疗效评估指标。我们建立了一种自然发生的犬类模型,患有XLMTM的犬类表现出与人类相似的临床症状。本研究的目的是确定该模型中评估未来治疗方法的潜在终点指标。我们选择了基于视频的步态分析,因为这是评估神经肌肉疾病肢体功能的一种成熟方法,而且相关测量指标与患者的生活质量相关。对3只XLMTM犬及其3只同窝野生型对照犬在4 - 5个时间点进行评估,从10周龄开始,持续到17周龄。分别使用动作捕捉和仪器化地毯来评估随时间变化的时空和运动学变化。与野生型犬相比,XLMTM犬行走速度更慢,步幅更短,而且随着时间推移这些差异变得更大。然而,患病犬和未患病犬在角度测量方面没有明显差异。这些数据表明,时空参数能够捕捉XLMTM犬类模型步态中的功能变化,并支持其在未来治疗试验中的应用。

相似文献

1
Gait characteristics in a canine model of X-linked myotubular myopathy.X连锁性肌管性肌病犬模型的步态特征
J Neurol Sci. 2014 Nov 15;346(1-2):221-6. doi: 10.1016/j.jns.2014.08.032. Epub 2014 Aug 29.
2
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.全身性腺相关病毒8介导的基因疗法驱动犬类肌管性肌病的全身纠正。
Mol Ther. 2017 Apr 5;25(4):839-854. doi: 10.1016/j.ymthe.2017.02.004. Epub 2017 Feb 22.
3
Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy.犬X连锁性中央核性肌病神经评分系统的有效性
Hum Gene Ther Clin Dev. 2015 Jun;26(2):131-7. doi: 10.1089/humc.2015.049.
4
Muscle function in a canine model of X-linked myotubular myopathy.X 连锁型肌小管肌病犬模型中的肌肉功能。
Muscle Nerve. 2012 Oct;46(4):588-91. doi: 10.1002/mus.23463.
5
Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.系统性基因治疗在犬类肌管性肌病模型中的长期效果。
Muscle Nerve. 2017 Nov;56(5):943-953. doi: 10.1002/mus.25658. Epub 2017 May 22.
6
Ultrasound assessment of the diaphragm: Preliminary study of a canine model of X-linked myotubular myopathy.膈肌的超声评估:X连锁肌管性肌病犬模型的初步研究。
Muscle Nerve. 2014 Oct;50(4):607-9. doi: 10.1002/mus.24294. Epub 2014 Aug 30.
7
Establishing clinical end points of respiratory function in large animals for clinical translation.建立用于临床转化的大型动物呼吸功能临床终点。
Phys Med Rehabil Clin N Am. 2012 Feb;23(1):75-94, xi. doi: 10.1016/j.pmr.2011.11.017. Epub 2011 Dec 15.
8
Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy.肌肉病理学、肢体力量、行走步态、呼吸功能和神经功能损害确定了X连锁肌管性肌病的p.N155K犬模型中的疾病进展。
Ann Transl Med. 2015 Oct;3(18):262. doi: 10.3978/j.issn.2305-5839.2015.10.31.
9
Clinical phenotype of X-linked myotubular myopathy in Labrador Retriever puppies.拉布拉多寻回犬幼犬X连锁肌管性肌病的临床表型。
J Vet Intern Med. 2015 Jan;29(1):254-60. doi: 10.1111/jvim.12513. Epub 2015 Jan 8.
10
rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.rAAV 相关治疗完全挽救了 X 连锁肌小管肌病的核和肌丝功能。
Acta Neuropathol Commun. 2020 Oct 19;8(1):167. doi: 10.1186/s40478-020-01048-8.

引用本文的文献

1
The Dog Model in the Spotlight: Legacy of a Trustful Cooperation.狗模型成为焦点:值得信赖合作的典范。
J Neuromuscul Dis. 2019;6(4):421-451. doi: 10.3233/JND-190394.
2
Kinetic and kinematic follow-up gait analysis in Doberman Pinschers with cervical spondylomyelopathy treated medically and surgically.对接受药物治疗和手术治疗的患有颈椎病的杜宾犬进行动力学和运动学随访步态分析。
J Vet Intern Med. 2018 May;32(3):1126-1132. doi: 10.1111/jvim.15096. Epub 2018 Mar 23.
3
Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.系统性基因治疗在犬类肌管性肌病模型中的长期效果。
Muscle Nerve. 2017 Nov;56(5):943-953. doi: 10.1002/mus.25658. Epub 2017 May 22.
4
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.全身性腺相关病毒8介导的基因疗法驱动犬类肌管性肌病的全身纠正。
Mol Ther. 2017 Apr 5;25(4):839-854. doi: 10.1016/j.ymthe.2017.02.004. Epub 2017 Feb 22.
5
Noninvasive Assessment of Neuromuscular Disease in Dogs: Use of the 6-minute Walk Test to Assess Submaximal Exercise Tolerance in Dogs with Centronuclear Myopathy.犬类神经肌肉疾病的无创评估:使用6分钟步行试验评估中央核性肌病犬的次最大运动耐量。
J Vet Intern Med. 2016 May;30(3):808-12. doi: 10.1111/jvim.13939. Epub 2016 Mar 25.
6
Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy.肌肉病理学、肢体力量、行走步态、呼吸功能和神经功能损害确定了X连锁肌管性肌病的p.N155K犬模型中的疾病进展。
Ann Transl Med. 2015 Oct;3(18):262. doi: 10.3978/j.issn.2305-5839.2015.10.31.
7
Gene therapy in monogenic congenital myopathies.单基因先天性肌病的基因治疗
Methods. 2016 Apr 15;99:91-8. doi: 10.1016/j.ymeth.2015.10.004. Epub 2015 Oct 14.
8
Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy.犬X连锁性中央核性肌病神经评分系统的有效性
Hum Gene Ther Clin Dev. 2015 Jun;26(2):131-7. doi: 10.1089/humc.2015.049.

本文引用的文献

1
Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.杜兴氏肌营养不良症男孩的日常生活活动参与情况及其与力量和功能指标的关系。
Disabil Rehabil. 2014;36(22):1918-23. doi: 10.3109/09638288.2014.883444. Epub 2014 Feb 6.
2
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.基因治疗可延长肌小管肌病的小鼠和犬模型的存活时间并恢复其功能。
Sci Transl Med. 2014 Jan 22;6(220):220ra10. doi: 10.1126/scitranslmed.3007523.
3
The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year.杜兴氏肌肉营养不良男孩与正常发育对照的6分钟步行测试及患者报告结局:纵向比较及一年期间具有临床意义的变化
PLoS Curr. 2013 Jul 8;5:ecurrents.md.9e17658b007eb79fcd6f723089f79e06. doi: 10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06.
4
Ambulation in adults with central neurologic disorders. Foreword.
Phys Med Rehabil Clin N Am. 2013 May;24(2):xi-xiii. doi: 10.1016/j.pmr.2012.12.002.
5
Quantitative phenotyping of Duchenne muscular dystrophy dogs by comprehensive gait analysis and overnight activity monitoring.通过全面步态分析和夜间活动监测对杜氏肌营养不良症犬进行定量表型分析。
PLoS One. 2013;8(3):e59875. doi: 10.1371/journal.pone.0059875. Epub 2013 Mar 27.
6
Motor assessment using the NIH Toolbox.使用 NIH 工具包进行运动评估。
Neurology. 2013 Mar 12;80(11 Suppl 3):S65-75. doi: 10.1212/WNL.0b013e3182872e01.
7
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.酶替代疗法可改善 X 连锁肌小管肌病小鼠的肌无力并改善其肌肉病理。
Hum Mol Genet. 2013 Apr 15;22(8):1525-38. doi: 10.1093/hmg/ddt003. Epub 2013 Jan 9.
8
Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.免疫抑制治疗对杜氏肌营养不良症 GRMD 犬模型的影响。
PLoS One. 2012;7(11):e48478. doi: 10.1371/journal.pone.0048478. Epub 2012 Nov 21.
9
Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.定量 MRI 与杜氏肌营养不良症自由行走能力丧失。
J Neurol. 2013 Apr;260(4):969-74. doi: 10.1007/s00415-012-6733-x. Epub 2012 Nov 9.
10
Gait abnormalities in type 1 myotonic muscular dystrophy: 3D motion analysis, energy cost and surface EMG.1型强直性肌营养不良症的步态异常:三维运动分析、能量消耗及表面肌电图
Comput Methods Biomech Biomed Engin. 2012;15 Suppl 1:171-2. doi: 10.1080/10255842.2012.713709.